This company seems to have been delisted
Reason: Acquired by Abbott
Last recorded trade on: June 30, 2023
Source: https://abbott.mediaroom.com/2023-04-27-Abbott-Completes-Acquisition-of-Cardiovascular-Systems,-Inc
Reason: Acquired by Abbott
Last recorded trade on: June 30, 2023
Source: https://abbott.mediaroom.com/2023-04-27-Abbott-Completes-Acquisition-of-Cardiovascular-Systems,-Inc
Cardiovascular Systems
CSII
NZ$33.26
Share price
0.15%
Change (1 day)
25.12%
Change (1 year)
Categories
Cardiovascular Systems (CSII) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : NZ$0.11 Billion
According to Cardiovascular Systems's latest financial reports the company's total liabilities are NZ$0.11 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cardiovascular Systems - Total liabilities on balance sheet (from 2004 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-06-30 | NZ$0.11 B | 0.56% |
| 2021-06-30 | NZ$0.11 B | 6.39% |
| 2020-06-30 | NZ$0.10 B | 4.36% |
| 2019-06-30 | NZ$0.10 B | 3.29% |
| 2018-06-30 | NZ$0.10 B | -1.44% |
| 2017-06-30 | NZ$0.10 B | 77.42% |
| 2016-06-30 | NZ$58.16 M | 23.78% |
| 2015-06-30 | NZ$46.99 M | 37.96% |
| 2014-06-30 | NZ$34.06 M | -12.34% |
| 2013-06-30 | NZ$38.85 M | 0.8% |
| 2012-06-30 | NZ$38.54 M | 27.1% |
| 2011-06-30 | NZ$30.32 M | -14.79% |
| 2010-06-30 | NZ$35.59 M | -45.72% |
| 2009-06-30 | NZ$65.57 M | |
| 2008-12-31 | NZ$8.09 M | -49.53% |
| 2007-12-31 | NZ$16.03 M | -82.4% |
| 2006-12-31 | NZ$91.11 M | -57.41% |
| 2005-12-31 | NZ$0.21 B | 111.21% |
| 2004-12-31 | NZ$0.10 B | |
| 2002-12-31 | NZ$32.3 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 AngioDynamics ANGO | NZ$0.16 B | 38.03% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | NZ$0.34 B | 189.02% | 🇺🇸 USA |
 Boston Scientific BSX | NZ$29.42 B | 24,435.13% | 🇺🇸 USA |
 Merit Medical MMSI | NZ$1.72 B | 1,341.48% | 🇺🇸 USA |
 Medtronic MDT | NZ$72.21 B | 60,113.26% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | NZ$192.17 B | 160,142.38% | 🇺🇸 USA |